Microelectrode Recording-Guided Deep Brain Stimulation in Patients with Movement Disorders.
- Author:
Sang Hyun KIM
1
;
Jong Hee CHANG
;
Jin Woo CHANG
;
Yong Gou PARK
;
Sang Sup CHUNG
Author Information
1. Department of Neurosurgery, Brain Research Institute, Yonsei University College of Medicine, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Deep brain stimulation(DBS);
Microelectrode recording;
Parkinson's disease;
Essential tremor;
Subthalamic nucleus;
Thalamus
- MeSH:
Activities of Daily Living;
Deep Brain Stimulation*;
Electrodes;
Essential Tremor;
Fires;
Humans;
Korea;
Microelectrodes*;
Movement Disorders*;
Parkinson Disease;
Substantia Nigra;
Subthalamic Nucleus;
Subthalamus;
Thalamus
- From:Journal of Korean Neurosurgical Society
2002;31(1):11-15
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: The authors analyzed the findings of microelectrode recording data and reported the surgical outcomes of movement disorder patients. METHODS: Since February 2000, the authors have used DBS for the movement disorders. We evaluated 4 patients who were followed more than 12 months after operation. One patient with essential tremor was treated with thalamic stimulation and three patients with idiopathic advanced Parkinson's disease with bilateral subthalamic nucleus stimulation. The electrodes were inserted under microelectrode recording. Clinical assessments were performed preoperatively and postoperatively by neurologist. RESULTS: All features of parkinsonian symptoms improved and the greatest benefit occurred in off-time and ADL. Interestingly our three patients with advanced Parkinson's disease did not have off-time after bilateral stimulation of subthalamic nucleus. There were no adverse side effects related to microelectrode recording or DBS procedure in all 4 patients. In our results of microelectrode recording of subthalamic nucleus, subthalamus showed higher firing rate than that of substantia nigra pars reticularis. Mean burst frequency of subthalamic nucleus was much higher than that of substantia nigra pars reticularis. CONCLUSION: The first trials of DBS in Korea also demonstrated favorable outcomes for movement disorders.
